Phosphoglycerate dehydrogenase (PHGDH), the first rate-limiting enzyme in the serine synthesis pathway, is elevated in ~70% of ER- breast cancers, and PHGDH inhibition showed an anti-proliferative effect [103]. The gene discussed is PHGDH; the disease is breast cancer.